Key result
Post-PCI coronary inflammation is linked to non-culprit lesion progression in ACS.
Why the study?
Non-culprit lesions can progress after primary PCI in patients with ACS, potentially affecting prognosis.
Does primary percutaneous coronary intervention (PCI) affect the progression of non-culprit lesions in patients with acute coronary syndrome (ACS)?
Does primary percutaneous coronary intervention (PCI) affect the progression of non-culprit lesions in patients with acute coronary syndrome (ACS)?
Coronary inflammation after primary PCI may be a pivotal factor affecting the progression of non-culprit lesions in ACS patients.
Post-PCI coronary inflammation may warrant closer non-culprit surveillance in ACS; hypothesis-generating for targeted intervention trials.
Primary percutaneous coronary intervention (PCI) is capable to relieve anginal symptoms, salvage dying myocardium and improve prognosis in patients with acute coronary syndrome (ACS). However, non-culprit lesions could progress after primary PCI, which might be a pivotal factor that affects
No takes yet. Share an insight, caveat, or question.
Bekki et al. (2024) studied this question. Coronary inflammation after percutaneous coronary intervention represents a potential risk factor for the progression of non-culprit lesions in patients with acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: